Home » Topics » Regulatory » Patents

Patents
RSS

Ancora Pharmaceuticals presents new vaccines for Staphylococcus infection

Nov. 21, 2012

GlaxoSmithKline synthesizes new bromodomain inhibitors

Nov. 21, 2012

Bayer Intellectual Property patents novel GCS activators

Nov. 21, 2012

New C. difficile vaccines patented by Pfizer

Nov. 21, 2012

Researchers at Bayer synthesize new cyclin-dependent kinase inhibitors

Nov. 21, 2012

NeuroSearch designs new modulators of neurotransmission

Nov. 20, 2012

Bayer patents new TTK inhibitors

Nov. 20, 2012

Santaris Pharma prepares novel antisense oligonucleotides

Nov. 20, 2012

New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus

Nov. 20, 2012

Novel mGlu5 receptor modulators disclosed by Roche

Nov. 20, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...